Funmi Olopade, MD named to National Cancer Advisory Board

March 15, 2017

Funmi Olopade, MD

Dr. Olufunmilayo Olopade, the Walter L. Palmer Distinguished Service Professor and Associate Dean for Global Health has been named as the recipient of the American Society of Clinical Oncology’s Humanitarian Award . First presented in 2011, the Humanitarian Award recognizes an oncologist who personifies ASCO’s mission and values by going above and beyond the call of duty in providing outstanding patient care through innovative means or exceptional service or leadership in the U.S.A. or abroad.

Dr. Olopade is an internationally renowned expert in breast cancer . Her laboratory research is focused on defining molecular mechanisms of cancer through studies of genetic and nongenetic factors contributing to tumor progression in at-risk individuals from diverse populations. Dr. Olopade found that women of African ancestry share a disproportionate burden of aggressive young onset breast cancer. She was the first to describe recurrent BRCA1 mutations in extended African American families and also provided the first report on BRCA1 and BRCA2 mutations in women from West Africa. Her work has increased the probability of improved outcomes for millions of women at risk for breast cancer and has bridged continents with her innovative research and service models.

ASCO and the Conquer Cancer Foundation of ASCO (CCF) announced the winners of their Special Awards, the Society’s highest honors, and the CCF Women Who Conquer Cancer Mentorship Award yesterday . The recipients of their awards include researchers, patient advocates, and global oncology leaders who have worked to transform cancer care around the world. ASCO will recognize this year’s awardees at the ASCO Annual Meeting in June.